Skip to content
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
SV
EN
Press releases
Start
/
Newsroom
/
Press releases
Press releases
News
Investor letter
Media bank
Press releases
News
Investor letter
Media bank
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2019
2019-10-07 10:26
SpectraCure to the Premier Segment of First North Growth Market
Regulatory
2019-09-24 16:27
Correction: Improved treatment technology in the fight against prostate cancer is used directly in an ongoing clinical trial
Regulatory
MAR
2019-09-24 14:35
Improved treatment technology in the fight against prostate cancer is used directly in an ongoing clinical trial
Regulatory
MAR
2019-09-16 10:15
SpectraCure presentations at investor meetings this fall
Regulatory
2019-08-22 10:40
SpectraCure strengthens the organization with a PR Manager
Regulatory
2019-08-21 14:00
SpectraCure AB Quarterly report (1 April to 30 June) 2019
Regulatory
MAR
2019-08-14 11:10
SpectraCures new generation P18
Regulatory
2019-07-08 09:45
Great attention for SpectraCure in Boston
Regulatory
2019-07-02 15:15
SpectraCure reports positive results from the company's clinical phase 1-study
Regulatory
MAR
2019-06-10 13:55
SpectraCure presents results from Phase 1 study
Regulatory
Previous
Next